{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T01:08:39Z","timestamp":1791940119346,"version":"4.3.4"},"reference-count":115,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T00:00:00Z","timestamp":1733184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>In China and other Asian nations, traditional medicine has long been utilized in the treatment of cardiovascular diseases (CVD). While Chinese authorities have incorporated traditional Chinese medicine (TCM) treatment experiences as a supplementary guide for CVD, its international recognition remains limited due to a scarcity of high-quality and reliable randomized controlled trials (RCTs) evidence. The purpose of this study was to examine the clinical outcomes with TCM for CVD after the recent publication of large trials adding &amp;gt;20,000 individuals to the published data. Here, we systematically reviewed 55 published RCTs (modified Jadad scores\u2009&amp;gt;\u20094) in the past 20 years, involving a total of 36,261 patients. In most studies, TCM has been associated with significant improvements in alternative endpoints such as hypertension, coronary heart disease, stroke and heart failure. A total of 19 trials reported on primary outcomes such as cardiovascular events and death events. During the follow-up period, some Chinese patent medicines can effectively reduce the \u201chard\u201d endpoints of coronary heart disease, stroke, and heart failure, the overall trend of cardiovascular outcomes is lower. The risk of adverse effects was not significantly increased compared to the control group, suggesting its potential as an alternative approach for primary and secondary prevention of CVD based on the available evidence.<\/jats:p>","DOI":"10.3389\/fcvm.2024.1419169","type":"journal-article","created":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T01:32:32Z","timestamp":1733189552000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["Traditional Chinese medicine for cardiovascular disease: efficacy and safety"],"prefix":"10.3389","volume":"11","author":[{"given":"Youwei","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanshan","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,12,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e153","DOI":"10.1161\/CIR.0000000000001052","article-title":"Heart disease and stroke statistics\u20142022 update: a report from the American Heart Association","volume":"145","author":"Tsao","year":"2022","journal-title":"Circulation"},{"key":"B2","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/S0140-6736(22)01441-6","article-title":"Metabolic, behavioural, and psychosocial risk factors and cardiovascular disease in women compared with men in 21 high-income, middle-income, and low-income countries: an analysis of the PURE study","volume":"400","author":"Walli-Attaei","year":"2022","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1093\/eurheartj\/ehab892","article-title":"European Society of cardiology: cardiovascular disease statistics 2021","volume":"43","author":"Timmis","year":"2022","journal-title":"Eur Heart J"},{"key":"B4","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur Heart J"},{"key":"B5","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1093\/eurheartj\/ehaa820","article-title":"Management of refractory angina: an update","volume":"42","author":"Davies","year":"2021","journal-title":"Eur Heart J"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2952","DOI":"10.1016\/j.jacc.2017.04.041","article-title":"Traditional Chinese medicine for cardiovascular disease","volume":"69","author":"Hao","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"B7","volume-title":"WHO traditional Medicine Strategy: 2014-2023","year":"2013"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.3969\/j.issn.1006-2157.2023.12.005","article-title":"Promoting the development of integrated Chinese and western medicine through crossing innovation","volume":"46","author":"Xu","year":"2023","journal-title":"J Beijing Univ Tranditional Chin Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/BF02836514","article-title":"Situation of integrative medicine in China: results from a national survey in 2004","volume":"12","author":"Chen","year":"2004","journal-title":"Chin J Integr Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nrcardio.2014.177","article-title":"Traditional Chinese medication for cardiovascular disease","volume":"12","author":"Hao","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"702110","DOI":"10.3389\/fcvm.2021.702110","article-title":"Traditional Chinese medicine for coronary artery disease treatment: clinical evidence from randomized controlled trials","volume":"8","author":"Liang","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/6181862","article-title":"Current status and evaluation of randomized clinical trials of traditional Chinese medicine in the treatment of cardiovascular diseases","volume":"2022","author":"Guo","year":"2022","journal-title":"Evid Based Complement Alternat Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"S100","DOI":"10.1038\/480S100a","article-title":"Perspective: the clinical trial barriers","volume":"480","author":"Liu","year":"2011","journal-title":"Nature"},{"key":"B14","doi-asserted-by":"publisher","first-page":"112","DOI":"10.7326\/M16-2977","article-title":"CONSORT Extension for Chinese herbal medicine formulas 2017: recommendations, explanation, and elaboration","volume":"167","author":"Cheng","year":"2017","journal-title":"Ann Intern Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2021-067476","article-title":"How to design high quality acupuncture trials\u2014a consensus informed by evidence","author":"Zhang","year":"2022","journal-title":"Br Med J"},{"key":"B16","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1056\/NEJMct0806114","article-title":"Acupuncture for chronic low back pain","volume":"363","author":"Berman","year":"2010","journal-title":"N Engl J Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/s41586-021-04001-4","article-title":"A neuroanatomical basis for electroacupuncture to drive the vagal\u2013adrenal axis","volume":"598","author":"Liu","year":"2021","journal-title":"Nature"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmj-2021-067475","article-title":"Evidence on acupuncture therapies is underused in clinical practice and health policy","volume":"376","author":"Lu","year":"2022","journal-title":"Br Med J"},{"key":"B19","doi-asserted-by":"publisher","first-page":"761","DOI":"10.7326\/M15-3118","article-title":"Acupuncture for chronic severe functional constipation: a randomized, controlled trial","volume":"165","author":"Liu","year":"2016","journal-title":"Ann Intern Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"100962","DOI":"10.1016\/j.arr.2019.100962","article-title":"Association of blood lipids, atherosclerosis and statin use with dementia and cognitive impairment after stroke: a systematic review and meta-analysis","volume":"57","author":"Yang","year":"2020","journal-title":"Ageing Res Rev"},{"key":"B21","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1001\/jamaoncol.2019.5233","article-title":"Clinical evidence for association of acupuncture and acupressure with improved cancer pain: a systematic review and meta-analysis","volume":"6","author":"He","year":"2020","journal-title":"JAMA Oncol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1001\/jamainternmed.2016.9378","article-title":"The long-term effect of acupuncture for migraine prophylaxis: a randomized clinical trial","volume":"177","author":"Zhao","year":"2017","journal-title":"JAMA Intern Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1001\/jamainternmed.2019.2407","article-title":"Acupuncture as adjunctive therapy for chronic stable angina: a randomized clinical trial","volume":"179","author":"Zhao","year":"2019","journal-title":"JAMA Intern Med"},{"key":"B24","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1111\/jch.13490","article-title":"Acupuncture for patients with mild hypertension: a randomized controlled trial","volume":"21","author":"Zheng","year":"2019","journal-title":"J Clin Hypertens"},{"key":"B25","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1142\/S0192415X12500516","article-title":"Acupuncture intervention in ischemic stroke: a randomized controlled prospective study","volume":"40","author":"Shen","year":"2012","journal-title":"Am J Chin Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.7661\/j.cjim.20191015.324","article-title":"Evidence-based medicine and future design ideas for acupuncture treatment of cardiovascular diseases","volume":"39","author":"C","year":"2019","journal-title":"Chin J Integr Tradit West Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1001\/jama.2022.19590","article-title":"Treatment of hypertension: a review","volume":"328","author":"Carey","year":"2022","journal-title":"JAMA"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.006056","article-title":"Antihypertensive medication adherence and risk of cardiovascular disease among older adults: a population-based cohort study","volume":"6","author":"Yang","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"B29","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1186\/s12872-017-0708-x","article-title":"Control of cardiovascular risk factors and its determinants in the general population- findings from the STAAB cohort study","volume":"17","author":"Tiffe","year":"2017","journal-title":"BMC Cardiovasc Disord"},{"key":"B30","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1093\/ajh\/hpv185","article-title":"Drug Side effect symptoms and adherence to antihypertensive medication","volume":"29","author":"Tedla","year":"2016","journal-title":"Am J Hypertens"},{"key":"B31","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s11906-017-0730-5","article-title":"The potential role of fibroblast growth factor 21 in lipid metabolism and hypertension","volume":"19","author":"Huang","year":"2017","journal-title":"Curr Hypertens Rep"},{"key":"B32","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1111\/jan.12361","article-title":"Factors associated with gender differences in medication adherence: a longitudinal study","volume":"70","author":"Chen","year":"2014","journal-title":"J Adv Nurs"},{"key":"B33","doi-asserted-by":"publisher","first-page":"745","DOI":"10.3321\/j.issn:1003-5370.2007.08.022","article-title":"Clinical observation on treatment of hypertension (yin-deficiency with sthenic-yang syndrome type) with zhongfu hypotension capsule [Chinese]","volume":"27","author":"Kou","year":"2007","journal-title":"Chin J Integr Tradit West Med"},{"key":"B34","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3969\/j.issn.1005-5304.2008.09.004","article-title":"Effects of jiangya capsule combined with nimodipine on depressurization and quality of life in elderly patients with isolated systolic hypertension [Chinese]","volume":"15","author":"H","year":"2008","journal-title":"Chin J Inf TCM."},{"key":"B35","doi-asserted-by":"publisher","first-page":"410","DOI":"10.3736\/jcim20100503","article-title":"Tranditional Chinese versus integrative treatment in elderly patients with isolated systolic hypertension: a multicenter, randomized, double-blind controlled trial","volume":"8","author":"Li","year":"2010","journal-title":"J Chin Integr Med"},{"key":"B36","first-page":"1","article-title":"A double-blind controlled study of the additional use of qiqilian capsules in the treatment of hypertension [Chinese]","volume":"17","author":"Ma","year":"2014","journal-title":"J Guangxi Univ Chin Med"},{"key":"B37","doi-asserted-by":"publisher","first-page":"801","DOI":"10.7661\/CJIM.2015.07.0801","article-title":"Treatment of level 2 hypertension by diagnosis and treatment program of integrative medicine: a multicentre. Randomized Controlled Trial [Chinese]","volume":"35","author":"Chen","year":"2015","journal-title":"Chin J Integr Tradit West Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"964","DOI":"10.3969\/j.issn.1008-049X.2015.06.025","article-title":"Randomized, double-blind, placebo control and multicenter clinical trials for tiankui antihypertension tablets combined with chemical drugs in the treatment of hypertension [Chinese]","volume":"18","author":"Wang","year":"2015","journal-title":"China Pharm"},{"key":"B39","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3969\/j.issn.1672-1349.2017.01.002","article-title":"The effect of angong jiangya pill in the treatment of grade-1 hypertension with liver-fire hyperactivity syndrome: a randomized controlled clincial trial [Chinese]","volume":"15","author":"Zhang D","year":"2017","journal-title":"Chin J Integr Med Cardio-Cerebrovasc Dis"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1161\/CIRCULATIONAHA.120.046685","article-title":"Treatment of masked hypertension with a Chinese herbal formula: a randomized, placebo-controlled trial","volume":"142","author":"Zhang","year":"2020","journal-title":"Circulation"},{"key":"B41","first-page":"836","article-title":"Clinical study on songlingxuemaikang capsule for the treatment of hypertension with losartan potassium tablets controlled [Chinese]","volume":"41","author":"Ma J","year":"2018","journal-title":"Drug Eval Res"},{"key":"B42","doi-asserted-by":"publisher","first-page":"e007923","DOI":"10.1161\/CIRCOUTCOMES.121.007923","article-title":"Efficacy and safety of Chinese herbal medicine compared with losartan for mild essential hypertension: a randomized, multicenter, double-blind, noninferiority trial","volume":"15","author":"Lai","year":"2022","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"B43","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1161\/01.HYP.0000241090.28070.4c","article-title":"Stop hypertension with the acupuncture research program (SHARP): results of a randomized, controlled clinical trial","volume":"48","author":"Macklin","year":"2006","journal-title":"Hypertension"},{"key":"B44","doi-asserted-by":"publisher","first-page":"3121","DOI":"10.1161\/CIRCULATIONAHA.106.661140","article-title":"Randomized trial of acupuncture to lower blood pressure","volume":"115","author":"Flachskampf","year":"2007","journal-title":"Circulation"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1161\/HYP.0b013e318293645f","article-title":"Beyond medications and diet: alternative approaches to lowering blood pressure: a scientific statement from the American Heart Association","volume":"61","author":"Brook","year":"2013","journal-title":"Hypertension"},{"key":"B46","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.ijcard.2013.09.001","article-title":"Acupuncture for essential hypertension","volume":"169","author":"Wang","year":"2013","journal-title":"Int J Cardiol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/14651858.CD008821.pub2","article-title":"Acupuncture for hypertension","volume":"2018","author":"Yang","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2023\/2722727","article-title":"Efficacy of acupuncture in the treatment of essential hypertension: an overview of systematic reviews and meta-analyses","volume":"2023","author":"Fan","year":"2023","journal-title":"Cardiovasc Ther"},{"key":"B49","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1016\/j.jacc.2020.08.078","article-title":"Evaluation and management of patients with stable angina: beyond the ischemia paradigm: jACC state-of-the-art review","volume":"76","author":"Ferraro","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(17)32714-9","article-title":"Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial","volume":"391","author":"Al-Lamee","year":"2018","journal-title":"Lancet Lond Engl"},{"key":"B51","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ijcard.2015.05.043","article-title":"Efficacy of electroacupuncture pretreatment for myocardial injury in patients undergoing percutaneous coronary intervention: a randomized clinical trial with a 2-year follow-up","volume":"194","author":"Wang","year":"2015","journal-title":"Int J Cardiol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1097\/00132580-200107000-00006","article-title":"Alternative approaches to the medical management of angina pectoris: acupuncture, electrical nerve stimulation, and spinal cord stimulation","volume":"3","author":"Bueno","year":"2001","journal-title":"Heart Dis Hagerstown Md"},{"key":"B53","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1142\/S0192415X99000197","article-title":"Effect of acupuncture at nei-kuan on left ventricular function in patients with coronary artery disease","volume":"27","author":"Ho","year":"1999","journal-title":"Am J Chin Med"},{"key":"B54","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.ijcard.2014.07.011","article-title":"A randomized controlled trial of acupuncture in stable ischemic heart disease patients","volume":"176","author":"Mehta","year":"2014","journal-title":"Int J Cardiol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1161\/01.CIR.71.2.308","article-title":"The effects of transcutaneous electrical nerve stimulation in patients with severe angina pectoris","volume":"71","author":"Mannheimer","year":"1985","journal-title":"Circulation"},{"key":"B56","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1093\/oxfordjournals.eurheartj.a059865","article-title":"Effect of acupuncture in patients with angina pectoris","volume":"12","author":"Richter","year":"1991","journal-title":"Eur Heart J"},{"key":"B57","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/j.1365-2796.1990.tb00114.x","article-title":"Effects of acupuncture in moderate, stable angina pectoris: a controlled study","volume":"227","author":"Ballegaard","year":"1990","journal-title":"J Intern Med"},{"key":"B58","first-page":"1051","article-title":"Efficacy assessment of treating patients with coronary heart disease angina of phlegm and stasis mutual obstruction syndrome by danlou tablet [Chinese]","volume":"32","author":"Wang","year":"2012","journal-title":"Chin J Integr Tradit West Med"},{"key":"B59","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s11655-014-1953-9","article-title":"A multicenter, randomized, double-blind clinical study on Wufuxinnaoqing soft capsule in treatment of chronic stable angina patients with blood stasis syndrome","volume":"21","author":"Zhang","year":"2015","journal-title":"Chin J Integr Med."},{"key":"B60","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1007\/s11655-015-2040-6","article-title":"Effect of Shenzhu Guanxin recipe on patients with angina pectoris after percutaneous coronary intervention: a prospective, randomized controlled trial","volume":"21","author":"Xu","year":"2015","journal-title":"Chin J Integr Med."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.19540\/j.cnki.cjcmm.20171226.002","article-title":"Effect of Xinling Wan in treatment of stable angina pectoris: a randomized, double-blinded, placebo parallel-controlled, multicenter trial [Chinese]","volume":"43","author":"Gao","year":"2018","journal-title":"China J Chin Mater Medica"},{"key":"B62","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1186\/s12906-019-2778-z","article-title":"Efficacy and safety of oral Guanxinshutong capsules in patients with stable angina pectoris in China: a prospective, multicenter, double-blind, placebo-controlled, randomized clinical trial","volume":"19","author":"Li","year":"2019","journal-title":"BMC Complement Altern Med"},{"key":"B63","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s11655-010-9999-9","article-title":"Effect of Xuefu Zhuyu capsule on the symptoms and signs and health-related quality of life in the unstable angina patients with blood-stasis syndrome after percutaneous coronary intervention: a randomized controlled trial","volume":"16","author":"Chu","year":"2010","journal-title":"Chin J Integr Med"},{"key":"B64","doi-asserted-by":"publisher","first-page":"116959","DOI":"10.1016\/j.jep.2023.116959","article-title":"Evaluation of the efficacy and safety of Suxiao Jiuxin pill in the treatment of stable angina: a randomized, double-blind, placebo-controlled, multi-center clinical trial","volume":"318","author":"Sun","year":"2024","journal-title":"J Ethnopharmacol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41569-020-0403-y","article-title":"Myocardial ischaemia-reperfusion injury and cardioprotection in perspective","volume":"17","author":"Heusch","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/S0140-6736(21)00272-5","article-title":"Mortality in STEMI patients without standard modifiable risk factors: a sex-disaggregated analysis of SWEDEHEART registry data","volume":"397","author":"Figtree","year":"2021","journal-title":"Lancet Lond Engl"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1001\/jamacardio.2022.2774","article-title":"Characteristics, process metrics, and outcomes among patients with ST-elevation myocardial infarction in rural vs urban areas in the US: a report from the US national cardiovascular data registry","volume":"7","author":"Hillerson","year":"2022","journal-title":"JAMA Cardiol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"H1967","DOI":"10.1152\/ajpheart.00944.2009","article-title":"The challenge of traditional Chinese medicines for allopathic practitioners","volume":"297","author":"Karalliedde","year":"2009","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1016\/j.amjcard.2008.02.056","article-title":"Effect of Xuezhikang, an extract from red yeast Chinese rice, on coronary events in a Chinese population with previous myocardial infarction","volume":"101","author":"Lu","year":"2008","journal-title":"Am J Cardiol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"2858","DOI":"10.3760\/cma.j.issn.0366-6999.2010.20.021","article-title":"No-reflow protection and long-term efficacy for acute myocardial infarction with tongxinluo: a randomized double-blind placebo-controlled multicenter clinical trial (ENLEAT trial)","volume":"123","author":"Zhang","year":"2010","journal-title":"Chin Med J (Engl)"},{"key":"B71","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1001\/jama.2023.19524","article-title":"Traditional Chinese medicine compound (tongxinluo) and clinical outcomes of patients with acute myocardial infarction: the CTS-AMI randomized clinical trial","volume":"330","author":"Yang","year":"2023","journal-title":"JAMA"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/738391","article-title":"Qi-Shen-Yi-Qi dripping pills for the secondary prevention of myocardial infarction: a randomised clinical trial","volume":"2013","author":"Shang","year":"2013","journal-title":"Evid Based Complement Alternat Med"},{"key":"B73","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1186\/s12906-016-1406-4","article-title":"Traditional Chinese medicine, danlou tablets alleviate adverse left ventricular remodeling after myocardial infarction: results of a double-blind, randomized, placebo-controlled, pilot study","volume":"16","author":"Mao","year":"2016","journal-title":"BMC Complement Altern Med"},{"key":"B74","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1001\/jamacardio.2019.0295","article-title":"Burden of cardiovascular diseases in China, 1990\u20132016: findings from the 2016 global burden of disease study","volume":"4","author":"Liu","year":"2019","journal-title":"JAMA Cardiol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1161\/CIRCULATIONAHA.118.033484","article-title":"Epidemic of cardiovascular disease in China: current perspective and prospects for the future","volume":"138","author":"Shen","year":"2018","journal-title":"Circulation"},{"key":"B76","doi-asserted-by":"publisher","first-page":"588","DOI":"10.3390\/molecules21050588","article-title":"In silico investigation of traditional Chinese medicine for potential lead compounds as SPG7 inhibitors against coronary artery disease","volume":"21","author":"Chen","year":"2016","journal-title":"Mol Basel Switz"},{"key":"B77","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","article-title":"2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes","volume":"41","author":"Knuuti","year":"2020","journal-title":"Eur Heart J"},{"key":"B78","doi-asserted-by":"publisher","first-page":"143145","DOI":"10.1155\/2015\/143145","article-title":"Cardiovascular disease, mitochondria, and traditional Chinese medicine","volume":"2015","author":"Wang","year":"2015","journal-title":"Evid-Based Complement Altern Med ECAM"},{"key":"B79","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3321\/j.issn:1003-5370.2006.01.006","article-title":"Clinical study on effect of Xiongshao capsule on restenosis after percutaneous coronary intervention","volume":"26","author":"Lu","year":"2006","journal-title":"Chin J Integr Tradit West Med."},{"key":"B80","doi-asserted-by":"publisher","first-page":"102209","DOI":"10.1016\/j.ctim.2019.102209","article-title":"Qing-Xin-Jie-Yu granule for patients with stable coronary artery disease (QUEST trial): a multicenter, double-blinded, randomized trial","volume":"47","author":"Li","year":"2019","journal-title":"Complement Ther Med"},{"key":"B81","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1089\/acm.2020.0361","article-title":"Effect of yugengtongyu granules in patients with stable coronary artery disease on reducing adverse cardiovascular events: a double-blind controlled trial","volume":"27","author":"Wang","year":"2021","journal-title":"J Altern Complement Med"},{"key":"B82","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s11655-022-3688-3","article-title":"Guanxin danshen dripping pills improve quality of life and cardiovascular prognoses of CHD patients after PCI with anxiety or depression (GLAD study): a randomized double-blind placebo-controlled study","volume":"29","author":"Wang","year":"2023","journal-title":"Chin J Integr Med"},{"key":"B83","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1089\/acm.2020.0014","article-title":"Effects on suxiao jiuxin pills in the treatment of patients with acute coronary syndrome undergoing early percutaneous coronary intervention: a multicenter randomized double-blind placebo-controlled trial","volume":"26","author":"Shen","year":"2020","journal-title":"J Altern Complement Med"},{"key":"B84","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1097\/CM9.0000000000001257","article-title":"Ef\ufb01cacy and safety of shexiang baoxin pill (MUSKARDIA) in patients with stable coronary artery disease: a multicenter, double-blind, placebo-controlled phase IV randomized clinical trial","volume":"134","author":"Ge","year":"2021","journal-title":"Chin Med J (Engl)"},{"key":"B85","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1097\/CM9.0000000000002527","article-title":"Effectiveness and safety of shexiang baoxin pill (MUSKARDIA) in patients with stable coronary artery disease and concomitant diabetes mellitus: a subgroup analysis of a randomized clinical trial","volume":"136","author":"Zhou","year":"2023","journal-title":"Chin Med J (Engl)"},{"key":"B86","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S0140-6736(15)00551-6","article-title":"Cause-specific mortality for 240 causes in China during 1990\u20132013: a systematic subnational analysis for the global burden of disease study 2013","volume":"387","author":"Zhou","year":"2016","journal-title":"Lancet Lond Engl"},{"key":"B87","doi-asserted-by":"publisher","first-page":"e897","DOI":"10.1016\/S2468-2667(21)00228-0","article-title":"Temporal trend and attributable risk factors of stroke burden in China, 1990\u20132019: an analysis for the global burden of disease study 2019","volume":"6","author":"Ma","year":"2021","journal-title":"Lancet Public Health"},{"key":"B88","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1016\/S0140-6736(16)00163-X","article-title":"Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials","volume":"387","author":"Goyal","year":"2016","journal-title":"Lancet Lond Engl"},{"key":"B89","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3969\/j.issn.1672-1519.2007.02.00","article-title":"Clinical study on Naoxin Duotai capsule in the treatment of hyperactivity of liver yang and blood stasis and obstruction of collaterals in the recovery period of ischemic stroke [Chinese]","volume":"24","author":"Han","year":"2007","journal-title":"Tianjin J Tradit Chin Med"},{"key":"B90","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1161\/STROKEAHA.108.531616","article-title":"Danqi piantang jiaonang (DJ), a traditional Chinese medicine, in poststroke recovery","volume":"40","author":"Chen","year":"2009","journal-title":"Stroke"},{"key":"B91","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.phymed.2010.10.004","article-title":"Radix\/rhizoma Notoginseng extract (sanchitongtshu) for ischemic stroke: a randomized controlled study","volume":"18","author":"He","year":"2011","journal-title":"Phytomedicine"},{"key":"B92","doi-asserted-by":"publisher","first-page":"e557","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.06.010","article-title":"The effect of Ginkgo biloba on functional outcome of patients with acute ischemic stroke: a double-blind, placebo-controlled, randomized clinical trial","volume":"22","author":"Oskouei","year":"2013","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"B93","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1161\/STROKEAHA.113.002055","article-title":"Chinese medicine neuroaid efficacy on stroke recovery: a double-blind, placebo-controlled, randomized study","volume":"44","author":"Chen","year":"2013","journal-title":"Stroke"},{"key":"B94","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1159\/000382082","article-title":"Chinese medicine NeuroAiD efficacy on stroke recovery\u2014extension study (CHIMES-E): a multicenter study of long-term efficacy","volume":"39","author":"Venketasubramanian","year":"2015","journal-title":"Cerebrovasc Dis"},{"key":"B95","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.ctim.2015.06.003","article-title":"The beneficial effects of the herbal medicine Di-huang-yin-zi (DHYZ) on patients with ischemic stroke: a randomized, placebo controlled clinical study","volume":"23","author":"Yu","year":"2015","journal-title":"Complement Ther Med"},{"key":"B96","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s11655-021-2857-0","article-title":"Efficacy of yangyin yiqi huoxue granule in treatment of ischemic stroke patients with qi-yin deficiency and blood stasis syndrome: a randomized, double-blind, multicenter, phase-2 clinical trial","volume":"27","author":"Wang","year":"2021","journal-title":"Chin J Integr Med"},{"key":"B97","doi-asserted-by":"publisher","first-page":"e2317574","DOI":"10.1001\/jamanetworkopen.2023.17574","article-title":"Efficacy and safety of Panax notoginseng saponins in the treatment of adults with ischemic stroke in China: a randomized clinical trial","volume":"6","author":"Wu","year":"2023","journal-title":"JAMA Netw Open"},{"key":"B98","doi-asserted-by":"publisher","first-page":"413","DOI":"10.3969\/j.issn.1000-3614.2015.05.002","article-title":"China heart failure registry study\u2014\u2014A multicenter, prospective investigation for preliminary analysis on etiology, clinical features and treatment in heart failure patients","volume":"30","author":"Jian","year":"2015","journal-title":"Chin Circ J"},{"key":"B99","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.3969\/j.issn.1000-3614.2021.11.001","article-title":"2021 Medical quality report of cardiovascular diseases in China: an executive summary","volume":"36","author":"Ma","year":"2021","journal-title":"Chin Circ J"},{"key":"B100","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/s0254-6272(18)30038-4","article-title":"Western medication plus traditional Chinese medicine preparations in patients with chronic heart failure: a prospective, single-blind, randomized, controlled, and multicenter clinical trial","volume":"37","author":"Wang","year":"2017","journal-title":"J Tradit Chin Med Chung Tsa Chih Ying Wen Pan"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1186\/1745-6215-10-122","article-title":"Study on the evaluation of the clinical effects of traditional Chinese medicine in heart failure by complex intervention: protocol of SECETCM-HF","volume":"10","author":"Mao","year":"2009","journal-title":"Trials"},{"key":"B102","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/j.jacc.2013.05.035","article-title":"A multicenter, Randomized122, double-blind, parallel-group, placebo-controlled study of the effects of qili qiangxin capsules in patients with chronic heart failure","volume":"62","author":"Li","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"B103","doi-asserted-by":"publisher","first-page":"3679","DOI":"10.4268\/cjcmm20161930","article-title":"Meta-analysis of supplemented zhenwu decoction for treating congestive heart-failure","volume":"41","author":"Wang","year":"2016","journal-title":"China J Chin Mater Medica"},{"key":"B104","doi-asserted-by":"publisher","first-page":"864","DOI":"10.3389\/fphar.2017.00864","article-title":"Mechanism of Chinese medicine herbs effects on chronic heart failure based on metabolic profiling","volume":"8","author":"Gao","year":"2017","journal-title":"Front Pharmacol"},{"key":"B105","first-page":"19","article-title":"Double blinded randomized and controlled study on treatment of chronic heart failure by nuanxin capsule [Chinese]","volume":"31","author":"Zou","year":"2011","journal-title":"Chin J Integr Tradit West Med"},{"key":"B106","first-page":"612","article-title":"Treatment of chronic heart failure by shencao tongmai granule: a multi-centered, double-blinded, randomized, parallel controlled trial [Chinese]","volume":"32","author":"Wang","year":"2012","journal-title":"Chin J Integr Tradit West Med"},{"key":"B107","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.13193\/j.archtcm.2012.06.11.zhangy.058","article-title":"A randomized clinical trail: the improvement of qi-reinforcing-blood-activating drugs on life quality in patients with chronic heart failure [Chinese]","volume":"30","author":"Zhang","year":"2012","journal-title":"Chin Arch Tradit Chin Med"},{"key":"B108","doi-asserted-by":"publisher","first-page":"808","DOI":"10.7661\/CJIM.2014.07.0808","article-title":"Treatment of chronic heart failure of Xin-shen yang deficiency. Interior retention of water-fuild syndrome by external application of zhuangshenling recipe combined with Western medicine: a clinical study [Chinese]","volume":"34","author":"Fu","year":"2014","journal-title":"Chin J Integr Tradit West Med"},{"key":"B109","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.4103\/0366-6999.209906","article-title":"Effects of traditional Chinese medicine shensong yangxin capsules on heart rhythm and function in congestive heart failure patients with frequent ventricular premature complexes: a randomized, double-blind, multicenter clinical trial","volume":"130","author":"Wang","year":"2017","journal-title":"Chin Med J (Engl)"},{"key":"B110","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s11655-015-2170-x","article-title":"Effect of yangxinkang tablets on chronic heart failure: a multi-center randomized double-blind placebocontrolled trial","volume":"21","author":"Xian","year":"2015","journal-title":"Chin J Integr Med"},{"key":"B111","doi-asserted-by":"publisher","first-page":"3881","DOI":"10.1002\/ehf2.12980","article-title":"Qishen yiqi dripping pills for chronic ischaemic heart failure: results of the CACT-IHF randomized clinical trial","volume":"7","author":"Mao","year":"2020","journal-title":"ESC Heart Fail"},{"key":"B112","doi-asserted-by":"publisher","first-page":"1017734","DOI":"10.3389\/fphar.2022.1017734","article-title":"The effects of qishen granules for patients with chronic heart failure: a multicenter randomized double-blind placebo-controlled trial","volume":"13","author":"Du","year":"2022","journal-title":"Front Pharmacol"},{"key":"B113","doi-asserted-by":"publisher","first-page":"831208","DOI":"10.3389\/fphar.2022.831208","article-title":"Efficacy and mechanism of buyang huanwu decoction in patients with ischemic heart failure: a randomized, double-blind, placebo-controlled trial combined with proteomic analysis","volume":"13","author":"Zhu","year":"2022","journal-title":"Front Pharmacol"},{"key":"B114","volume-title":"First Randomised Trial of Traditional Chinese Medicine for Heart Failure Shows Benefit","author":"Li","year":"2023"},{"key":"B115","doi-asserted-by":"publisher","first-page":"4305","DOI":"10.1093\/eurheartj\/ehae532","article-title":"Atrial tachyarrhythmia prevention by Shensong Yangxin after catheter ablation for persistent atrial fibrillation: the SS-AFRF trial","volume":"45","author":"Huang","year":"2024","journal-title":"Eur Heart J"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2024.1419169\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T01:32:51Z","timestamp":1733189571000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2024.1419169\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,3]]},"references-count":115,"alternative-id":["10.3389\/fcvm.2024.1419169"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2024.1419169","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,3]]},"article-number":"1419169"}}